Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosaisolated from patients with cystic fibrosis

Molecular Medicine Reports

Volumn 11, Issue 1, 2015, Pages 494-498

  Li, Yongwei ^a,b   Zhang, Xiaoqian ^b   Wang, Chunxia ^b   Hu, Yue ^b   Niu, Xiaobin ^b   Pei, Dongxu ^b   He, Zhiqiang ^b   Bi, Yongyi ^a  

^a WUHAN UNIVERSITY   (China)

^b HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cystic Fibrosis; Metallo Lactamase; Pseudomonas Aeruginosa

Indexed keywords

AMIKACIN; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; EDETIC ACID; GATIFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN; TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CYSTIC FIBROSIS; DEMOGRAPHY; FEMALE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; QUESTIONNAIRE; COMPLICATION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PRESCHOOL CHILD; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

EID: 84916243301     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2685     Document Type: Article

References (40)

1. Friend PA: Pulmonary infection in cystic fbrosis. J Infect 13: 55-72, 1986.
2. Kulczycki LL, Murphy TM and Bellanti JA: Pseudomonas colonization in cystic fbrosis. A study of 160 patients. JAMA 240: 30-34, 1978.
3. May JR, Herrick NC and Thompson D: Bacterial infection in cystic fbrosis. Arch Dis Child 47: 908-913, 1972.
4. Mearns MB, Hunt GH and Rushworth R: Bacterial fora of respiratory tract in patients with cystic fbrosis, 1950-1971. Arch Dis Child 47: 902-907, 1972.
5. Thomassen MJ, Demko CA, Boxerbaum B, et al: Multiple isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fbrosis. J Infect Dis 140: 873-880, 1979.
6. Arancibia F, Bauer TT, Ewig S, et al: Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 162: 1849-1858, 2002.
7. West SE, Zeng L, Lee BL, et al: Respiratory infections with Pseudomonas aeruginosa in children with cystic fbrosis: early detection by serology and assessment of risk factors. JAMA 287: 2958-2967, 2002.
8. Spilker T, Coenye T, Vandamme P, and LiPuma JJ: PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fbrosis patients. J Clin Microbiol 42: 2074-2079, 2004.
9. Gillespie SH and Hawkey PM: Principles and Practice of Clinical Bacteriology. 2nd edition. Wiley, Chichester, UK. 2006.
10. Lyczak JB, Cannon CL and Pier GB: Lung infections associated with cystic fbrosis. Clin Microbiol Rev 15: 194-222, 2002.
11. Nikaido H: Multidrug effux pumps of gram-negative bacteria. J Bacteriol 178: 5853-5859, 1996.
12. Sonnesyn SW and Gerding DN: Antimicrobials for the treatment of respiratory infections. In: Respiratory Infections: A Scientifc Basis for Management. Niederman MS, Sarosi GA and Glassroth J (eds). Saunders, Philadelphia, pp511-537, 1994.
13. Lee K, Lim YS, Yong D, et al: Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41: 4623-4629, 2003.
14. Varaiya A, Kulkarni N, Kulkarni M, et al: Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients. Indian J Med Res 127: 398-402, 2008.
15. Oh EJ, Lee S, Park YJ, et al: Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamase. J Microbiol Methods 54: 411-418, 2003.
16. Pitout JD, Gregson DB, Poirel L, et al: Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory. J Clin Microbiol 43: 3129-3135, 2005.
17. Gladstone P, Rajendran P and Brahmadathan KN: Incidence of carbapenem resistant nonfermenting gram negative bacilli from patients with respiratory infections in the intensive care units. Indian J Med Microbiol 23: 189-191, 2005.
18. Cornaglia G, Mazzariol A, Lauretti L, et al: Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin Infect Dis 31: 1119-1125, 2000.
19. Crespo M P, Woodford N, Sinclair A, et al: Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol 42: 5094-5101, 2004.
20. Pournaras S, Maniati M, Petinaki E, et al: Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4. J Antimicrob Chemother 51: 1409-1414, 2003.
21. Tsakris AS, Pournaras S, Woodford M, et al: Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carba penemasein Greece. J Clin Microbiol 38: 1290-1292, 2000.
22. Yong D, Lee K, Yum JH, et al: Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 40: 3798-3801, 2002.
23. Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing. 11th informational supplement. CLSI, Wayne, PA, USA, M100-S23, 2013.
24. Hall BG and Barlow M: Revised Ambler classification of β-lactamases. J Antimicrob Chemother 55: 1050-1051, 2005.
25. Pitt TL, Sparrow M, Warner M and Stefanidou M: Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fbrosis to six commonly prescribed antimicrobial agents. Thorax 58: 794-796, 2003.
26. Cheng K, Smyth RL, Govan JR, et al: Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fbrosis clinic. Lancet 348: 639-642, 1996.
27. Gales AC, Jones RN, Turnidge J, et al: Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 32 Suppl 2: S146-S155, 2001.
28. Neuhauser MM, Weinstein RA, Rydman R, et al: Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fuoroquinolone use. JAMA 289: 885-888, 2003.
29. Cardoso O, Alves AF and Leitão R: Metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fbrosis patient. Int J Antimicrob Agents 31: 375-379, 2008.
30. Manoharan A, Chatterjee S and Mathai D; SARI Study Group: Detection and characterization of metallo beta lactamases producing Pseudomonas aeruginosa. Indian J Med Microbiol 28: 241-244, 2010.
31. Behera B, Mathur P, Das A, et al: An evaluation of four different phenotypic techniques for detection of metallo-beta-lactamase producing Pseudomonas aeruginosa. Indian J Med Microbiol 26: 233-237, 2008.
32. Hemlatha V, Sekar U and Kamat V: Detection of metallo beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 122: 148-152, 2005.
33. Hemlatha V, Sekar U and Kamat V: Detection of metallo betalactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 122: 148-152, 2005.
34. Mayank D, Anshuman M, Singh RK, et al: Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Indian J Pathol Microbiol 52: 509-513, 2009.
35. Obritsch MD, Fish DN, MacLaren R and Jung R: National surveillance of antimicrobial resistance in Pseudomonas aeru-ginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 48: 4606-4610, 2004.
36. Arya M, Arya PK, Biswas D and Prasad R: Antimicrobial susceptibility pattern of bacterial isolates from post-operative wound infections. Indian J Pathol Microbiol 48: 266-269, 2005.
37. Migliavacca R, Docquier JD, Mugnaioli C, et al: Simple micro-dilution test for detection of metallo-β-lactamase production in Pseudomonas aeruginosa. J Clin Microbiol 40: 4388-4390, 2002.
38. Aggarwal R, Chaudhary U and Bala K: Detection of extended-spectrum beta lactamase in Pseudomonas aeruginosa. Indian J Pathol Microbiol 51: 222-224, 2008.
39. Jayakumar S and Appalaraju B: Prevalence of multi and pan drug resistant Pseudomonas aeruginosa with respect to ESBL and MBL in a tertiary care hospital. Indian J Pathol Microbiol 50: 922-925, 2007.
40. Sader HS, Reis AO, Silbert S and Gales AC: IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin Microbiol Infect 11: 73-76, 2005.